Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Abelzeta Inc. currently has 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 2 distinct examiners and 2 distinct art units. This distribution shows that the company's active prosecution is spread across different specialized groups within the biotechnology sector. Managing 2 distinct examiners and 2 distinct art units requires a more diverse prosecution strategy to account for varying examination standards and technical expertise.
The busiest examiner for the portfolio is FERNANDEZ, SUSAN EMILY, who is responsible for 1 pending office action. Although there are 2 pending office actions in total, the busiest examiner pending count is 1, meaning the workload is split between the available examiners. Practitioners must manage the relationship with FERNANDEZ, SUSAN EMILY and the other assigned official to successfully advance the company's current patent applications. This split workload necessitates a careful balancing of resources to ensure that each of the 2 pending office actions receives the appropriate level of attention.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FERNANDEZ, SUSAN EMILY | 1 | 52.5% | +60.8% |
| BEHARRY, ZANNA MARIA | 1 | 24.7% | +56.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18044263 | METHODS FOR LYSING BACTERIAL CELLS | FERNANDEZ, SUSAN EMILY | 12d |
| 17631006 | UNIVERSAL CAR-T CELL AND PREPARATION AND USE THEREOF | BEHARRY, ZANNA MARIA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18044263 | METHODS FOR LYSING BACTERIAL CELLS | FERNANDEZ, SUSAN EMILY | 12d |
| 17631006 | UNIVERSAL CAR-T CELL AND PREPARATION AND USE THEREOF | BEHARRY, ZANNA MARIA | — |
| Art Unit | Apps |
|---|---|
| 1651 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18044263 | METHODS FOR LYSING BACTERIAL CELLS | FERNANDEZ, SUSAN EMILY | 1651 | §103§112 | Non-Final OA | 12d | Pending | Mar 07, 2023 |
| 17631006 | UNIVERSAL CAR-T CELL AND PREPARATION AND USE THEREOF | BEHARRY, ZANNA MARIA | 1632 | §103§112 | Non-Final OA | — | Pending | Aug 09, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial